Mirae Asset Global Investments’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.2K | Buy |
12,900
+1,929
| +18% | +$3.32K | ﹤0.01% | 1385 |
|
|
2025
Q1 | $39.1K | Buy |
10,971
+815
| +8% | +$2.9K | ﹤0.01% | 1288 |
|
|
2024
Q4 | $74.9K | Sell |
10,156
-822
| -7% | -$6.06K | ﹤0.01% | 1197 |
|
|
2024
Q3 | $105K | Buy |
10,978
+2,624
| +31% | +$25.2K | ﹤0.01% | 1178 |
|
|
2024
Q2 | $66.9K | Sell |
8,354
-79,924
| -91% | -$640K | ﹤0.01% | 1192 |
|
|
2024
Q1 | $772K | Sell |
88,278
-54,668
| -38% | -$478K | ﹤0.01% | 1675 |
|
|
2023
Q4 | $1.16M | Sell |
142,946
-5,068
| -3% | -$41.2K | ﹤0.01% | 1535 |
|
|
2023
Q3 | $673K | Buy |
148,014
+12,852
| +10% | +$58.5K | ﹤0.01% | 1744 |
|
|
2023
Q2 | $952K | Buy |
135,162
+25,791
| +24% | +$182K | ﹤0.01% | 1594 |
|
|
2023
Q1 | $668K | Buy |
109,371
+43,037
| +65% | +$263K | ﹤0.01% | 1779 |
|
|
2022
Q4 | $424K | Buy |
66,334
+56
| +0.1% | +$358 | ﹤0.01% | 1978 |
|
|
2022
Q3 | $635K | Buy |
66,278
+19,139
| +41% | +$183K | ﹤0.01% | 1734 |
|
|
2022
Q2 | $520K | Buy |
+47,139
| New | +$520K | ﹤0.01% | 1730 |
|
|
2019
Q1 | – | Sell |
-91,506
| Closed | -$810K | – | 1334 |
|
|
2018
Q4 | $810K | Buy |
91,506
+38,083
| +71% | +$337K | 0.01% | 828 |
|
|
2018
Q3 | $601K | Buy |
+53,423
| New | +$601K | ﹤0.01% | 985 |
|